Promakhos Therapeutics Alternatives & Competitors

12 companies similar to Promakhos Therapeutics — Creating transformative medicines for patients with inflammatory diseases.

Noa Therapeutics

Noa Therapeutics is transforming the treatment of inflammatory barrier diseases.

13 Seed $500.00K

Toronto, Canada

Biotechnology

Tridek-One

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...

12 Series Unknown $19.00M

Paris, France

Biotechnology Health Care +1

Sitryx

Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...

48 Series A $79.00M

Oxford, United Kingdom

Biotechnology Health Care +1

Landos Biopharma, Inc.

28 Series B $70.00M

Blacksburg, United States

Biopharma Biotechnology +3

Track all Promakhos Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Mammoth Biosciences

Improving lives by reading and writing the code of life.

164 Unknown $363.22M

Brisbane, United States

Biotechnology Health Care +1

Mogrify

Transforming the lives of patients with degenerative diseases through a novel class of in...

11 Series A $47.80M

Cambridge, United Kingdom

Big Data Biotechnology +4

Seismic Therapeutic

The Machine Learning Immunology Company

49 Series B $222.00M

Watertown, United States

Biotechnology Health Care +1

Nucleome Therapeutics

Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision m...

52 Series A $45.20M

Oxford, United Kingdom

Harness Therapeutics

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases

34 Series Unknown $17.70M

Cambridge, United Kingdom

Biotechnology Life Sciences

Gandeeva Therapeutics

Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...

23 Series A $40.00M

Canada

Biotechnology Health Care +1

Azome Therapeutics

Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases

3 Seed

Biopharma Biotechnology +1

Verge Genomics

Better drugs, faster. For patients who can’t wait.

28 Series B $134.00M

South San Francisco, Unit...

Biotechnology Health Care +1

About Promakhos Therapeutics

Creating transformative medicines for patients with inflammatory diseases.

Services

Development of non-immunosuppressive therapies, Preclinical drug validation, Scientific research and innovation, Translational research, Clinical trials for inflammatory diseases

Target Customers

Patients with inflammatory diseases, Healthcare providers, Biotech and pharmaceutical companies, Research institutions, Innovative therapeutics investors

Taxonomy

Inflammation, Defend, Healing, Cures, Inflammatory Disorders, Medical

Business Model

B2B, B2C, B2D

Revenue Model

Licensing, Performance Based, Product Sales

Frequently Asked Questions

Top alternatives to Promakhos Therapeutics include Noa Therapeutics, Tridek-One, Sitryx, Landos Biopharma, Inc., Mammoth Biosciences. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Promakhos Therapeutics based on industry overlap, target customers, and business model.

Creating transformative medicines for patients with inflammatory diseases.

Don't just read about them. Follow them.

BounceWatch watches Promakhos Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Promakhos Therapeutics Profile Noa Therapeutics Alternatives Tridek-One Alternatives Sitryx Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Promakhos Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.